227 related articles for article (PubMed ID: 29288502)
1. Type III interferons are critical host factors that determine susceptibility to Influenza A viral infection in allergic nasal mucosa.
Jeon YJ; Lim JH; An S; Jo A; Han DH; Won TB; Kim DY; Rhee CS; Kim HJ
Clin Exp Allergy; 2018 Mar; 48(3):253-265. PubMed ID: 29288502
[TBL] [Abstract][Full Text] [Related]
2. Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus.
Kim HJ; Jo A; Jeon YJ; An S; Lee KM; Yoon SS; Choi JY
Microbiome; 2019 May; 7(1):80. PubMed ID: 31146794
[TBL] [Abstract][Full Text] [Related]
3. Initial Influenza Virus Replication Can Be Limited in Allergic Asthma Through Rapid Induction of Type III Interferons in Respiratory Epithelium.
An S; Jeon YJ; Jo A; Lim HJ; Han YE; Cho SW; Kim HY; Kim HJ
Front Immunol; 2018; 9():986. PubMed ID: 29867963
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species induce antiviral innate immune response through IFN-λ regulation in human nasal epithelial cells.
Kim HJ; Kim CH; Ryu JH; Kim MJ; Park CY; Lee JM; Holtzman MJ; Yoon JH
Am J Respir Cell Mol Biol; 2013 Nov; 49(5):855-65. PubMed ID: 23786562
[TBL] [Abstract][Full Text] [Related]
5. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
Rowe T; Davis W; Wentworth DE; Ross T
J Virol; 2024 Feb; 98(2):e0149423. PubMed ID: 38294251
[TBL] [Abstract][Full Text] [Related]
6. Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis.
Głobińska A; Pawełczyk M; Piechota-Polańczyk A; Olszewska-Ziąber A; Moskwa S; Mikołajczyk A; Jabłońska A; Zakrzewski PK; Brauncajs M; Jarzębska M; Taka S; Papadopoulos NG; Kowalski ML
Clin Exp Immunol; 2017 Jan; 187(1):100-112. PubMed ID: 27667736
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial reactive oxygen species modulate innate immune response to influenza A virus in human nasal epithelium.
Kim S; Kim MJ; Park DY; Chung HJ; Kim CH; Yoon JH; Kim HJ
Antiviral Res; 2015 Jul; 119():78-83. PubMed ID: 25930096
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung.
Kim BJ; Cho SW; Jeon YJ; An S; Jo A; Lim JH; Kim DY; Won TB; Han DH; Rhee CS; Kim HJ
Appl Microbiol Biotechnol; 2018 Jan; 102(1):105-115. PubMed ID: 28936773
[TBL] [Abstract][Full Text] [Related]
9. Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis.
Jha A; Thwaites RS; Tunstall T; Kon OM; Shattock RJ; Hansel TT; Openshaw PJM
J Allergy Clin Immunol; 2021 Feb; 147(2):694-703.e12. PubMed ID: 32717253
[TBL] [Abstract][Full Text] [Related]
10. The Induction of Pattern-Recognition Receptor Expression against Influenza A Virus through Duox2-Derived Reactive Oxygen Species in Nasal Mucosa.
Kim HJ; Kim CH; Kim MJ; Ryu JH; Seong SY; Kim S; Lim SJ; Holtzman MJ; Yoon JH
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):525-35. PubMed ID: 25751630
[TBL] [Abstract][Full Text] [Related]
11. Symbiotic microbiome Staphylococcus aureus from human nasal mucus modulates IL-33-mediated type 2 immune responses in allergic nasal mucosa.
Jeon YJ; Gil CH; Won J; Jo A; Kim HJ
BMC Microbiol; 2020 Oct; 20(1):301. PubMed ID: 33028252
[TBL] [Abstract][Full Text] [Related]
12. Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.
Ramos I; Smith G; Ruf-Zamojski F; Martínez-Romero C; Fribourg M; Carbajal EA; Hartmann BM; Nair VD; Marjanovic N; Monteagudo PL; DeJesus VA; Mutetwa T; Zamojski M; Tan GS; Jayaprakash C; Zaslavsky E; Albrecht RA; Sealfon SC; García-Sastre A; Fernandez-Sesma A
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375585
[TBL] [Abstract][Full Text] [Related]
13. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
[TBL] [Abstract][Full Text] [Related]
14. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma.
Patel DA; You Y; Huang G; Byers DE; Kim HJ; Agapov E; Moore ML; Peebles RS; Castro M; Sumino K; Shifren A; Brody SL; Holtzman MJ
J Allergy Clin Immunol; 2014 Dec; 134(6):1402-1412.e7. PubMed ID: 25216987
[TBL] [Abstract][Full Text] [Related]
15. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
16. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
Jeon YJ; Gil CH; Jo A; Won J; Kim S; Kim HJ
Antiviral Res; 2020 Aug; 180():104860. PubMed ID: 32565134
[TBL] [Abstract][Full Text] [Related]
17. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy.
Spann KM; Baturcam E; Schagen J; Jones C; Straub CP; Preston FM; Chen L; Phipps S; Sly PD; Fantino E
Thorax; 2014 Oct; 69(10):918-25. PubMed ID: 24811725
[TBL] [Abstract][Full Text] [Related]
18. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
19. A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
Shepardson K; Larson K; Cho H; Johns LL; Malkoc Z; Stanek K; Wellhman J; Zaiser S; Daggs-Olson J; Moodie T; Klonoski JM; Huber VC; Rynda-Apple A
Viral Immunol; 2019 Apr; 32(3):131-143. PubMed ID: 30822217
[TBL] [Abstract][Full Text] [Related]
20. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
Ye L; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
